Case: Patents/Anticipation & Obviousness (P.T.A.B.)

The Patent Trial and Appeal Board determined that challenged claims of Tecan Genomics Inc.'s patent titled “Compositions and Methods for Identification of a Duplicate Sequencing Read” are unpatentable as anticipated by or obvious over prior art, in an inter partes review by Integrated DNA Technologies Inc. The board said that the challenged claims are anticipated by or obvious over prior art titled “Methods for Determining a Nucleotide Sequence,” “Counting Absolute Numbers of Molecules Using Unique Molecular Identifiers,” and “Compositions and Methods for Accurately Identifying Mutations.”